PE20021098A1 - ANTICUERPOS ESPECIFICOS DE CD44v6 - Google Patents

ANTICUERPOS ESPECIFICOS DE CD44v6

Info

Publication number
PE20021098A1
PE20021098A1 PE2002000422A PE2002000422A PE20021098A1 PE 20021098 A1 PE20021098 A1 PE 20021098A1 PE 2002000422 A PE2002000422 A PE 2002000422A PE 2002000422 A PE2002000422 A PE 2002000422A PE 20021098 A1 PE20021098 A1 PE 20021098A1
Authority
PE
Peru
Prior art keywords
refers
antibody
specific antibodies
proteins
sequence
Prior art date
Application number
PE2002000422A
Other languages
English (en)
Spanish (es)
Inventor
Gunther Adolf
Karl-Heinz Heider
John J Miglietta
Dongen Augustinus Antonjus Maria Silvester Van
Erik Patzelet
Marlies Sproll
Elinborg Ostermann
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Int
Publication of PE20021098A1 publication Critical patent/PE20021098A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PE2002000422A 2001-05-18 2002-05-17 ANTICUERPOS ESPECIFICOS DE CD44v6 PE20021098A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01112237 2001-05-18
US32514701P 2001-09-26 2001-09-26

Publications (1)

Publication Number Publication Date
PE20021098A1 true PE20021098A1 (es) 2003-02-11

Family

ID=33442672

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000422A PE20021098A1 (es) 2001-05-18 2002-05-17 ANTICUERPOS ESPECIFICOS DE CD44v6

Country Status (18)

Country Link
EP (1) EP1397387A1 (fr)
JP (1) JP2005504517A (fr)
CN (1) CN1541226A (fr)
AR (1) AR036154A1 (fr)
BR (1) BR0210905A (fr)
CA (1) CA2443437A1 (fr)
CZ (1) CZ20033476A3 (fr)
EA (1) EA200301169A1 (fr)
EC (1) ECSP034838A (fr)
EE (1) EE200300569A (fr)
HU (1) HUP0400030A3 (fr)
MX (1) MXPA03010523A (fr)
PE (1) PE20021098A1 (fr)
PL (1) PL365735A1 (fr)
SK (1) SK15592003A3 (fr)
WO (1) WO2002094879A1 (fr)
YU (1) YU91403A (fr)
ZA (1) ZA200307365B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071072B2 (en) 1999-10-08 2011-12-06 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) 1999-10-08 2011-05-24 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8048416B2 (en) 1999-10-08 2011-11-01 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7084257B2 (en) 2001-10-05 2006-08-01 Amgen Inc. Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
US20050232919A1 (en) 2004-02-12 2005-10-20 Morphotek, Inc. Monoclonal antibodies that specifically block biological activity of a tumor antigen
AU2006223301B2 (en) 2005-03-10 2010-11-04 Eisai, Inc. Anti-mesothelin antibodies
EP2172487A1 (fr) 2005-04-22 2010-04-07 Morphotek Inc. Anticorps presentant une activite d'effecteur immunitaire et s'internalisant dans des cellues positives de recepteur alpha de folate
LT2167038T (lt) * 2007-06-13 2018-05-25 Zymogenetics, Inc. Taci-ig sulieto baltymo, tokio kaip ataciceptas, panaudojimas gamybai vaisto, skirto raudonajai vilkligei gydyti
EP2009028A1 (fr) * 2007-06-27 2008-12-31 Monoclonal Antibodies Therapeutics Combinaison d'un traitement anti-cancer conventionnel avec administration d'anticorps anti-CD44 pour traiter de graves tumeurs
PT2531527E (pt) 2010-02-04 2014-05-16 Hoffmann La Roche Anticorpo monoclonal contra cd44 para ser utilizado no tratamento de carcinoma de células escamosas da cabeça e do pescoço
CN102337298B (zh) * 2011-08-19 2013-11-06 黄开红 一种输送siRNA的免疫纳米载体及其制备方法和应用
WO2013083497A1 (fr) 2011-12-06 2013-06-13 F. Hoffmann-La Roche Ag Formulation d'anticorps
WO2017215637A1 (fr) * 2016-06-15 2017-12-21 李翀 Marqueur du cancer de l'endomètre humain, anticorps et application de l'anticorps
CN107556388A (zh) * 2016-06-30 2018-01-09 中国科学院深圳先进技术研究院 抗CD44v6和CD3特异性双靶向抗体、含该双靶向抗体表达盒的微环DNA及应用
WO2022187591A1 (fr) * 2021-03-05 2022-09-09 Go Therapeutics, Inc. Anticorps anti-glyco-cd44 et leurs utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
EP0438310A1 (fr) * 1990-01-19 1991-07-24 Merck & Co. Inc. Méthode de production d'immunoglobulines recombinantes
GB9020282D0 (en) * 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation
CA2149635A1 (fr) * 1992-11-20 1994-06-09 David Tarin Peptide correspondant a l'exon 6 du gene cd44, anticorps specifiques de ce peptide et utilisation de ces anticorps pour le diagnostic de tumeurs
UA58482C2 (uk) * 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти
UY24389A1 (es) * 1995-12-06 2001-10-25 Karlsruhe Forschzent Composición farmacéutica para el tratamiento de carcinoma de epitelio plano

Also Published As

Publication number Publication date
YU91403A (sh) 2006-05-25
PL365735A1 (en) 2005-01-10
EP1397387A1 (fr) 2004-03-17
JP2005504517A (ja) 2005-02-17
BR0210905A (pt) 2004-06-08
SK15592003A3 (sk) 2004-06-08
EE200300569A (et) 2004-04-15
CN1541226A (zh) 2004-10-27
AR036154A1 (es) 2004-08-18
CZ20033476A3 (cs) 2004-05-12
ZA200307365B (en) 2004-05-10
CA2443437A1 (fr) 2002-11-28
MXPA03010523A (es) 2004-07-01
ECSP034838A (es) 2003-12-24
HUP0400030A3 (en) 2006-02-28
EA200301169A1 (ru) 2004-06-24
WO2002094879A1 (fr) 2002-11-28
HUP0400030A2 (hu) 2004-04-28

Similar Documents

Publication Publication Date Title
PE20021098A1 (es) ANTICUERPOS ESPECIFICOS DE CD44v6
CY1118467T1 (el) Σκευασματα αντισωματων και πρωτεϊνων υψηλης συγκεντρωσης
ATE382053T1 (de) System zur antikörperexpression und- synthese
PE20070684A1 (es) MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP
DE602006010072D1 (de) Il-1 bindende antikörper und fragmente davon
EP1067182A8 (fr) Proteine secretoire ou proteine de membrane
ATE510011T1 (de) Neue pilzproteine und diese codierende nukleinsäuren
DK2014678T3 (da) KDR-peptider og vacciner indeholdende disse
BRPI0616712B8 (pt) método para amidar polipeptídeos com terminais c de aminoácido básicos por meio de endoproteases específicas
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
DK1534830T3 (da) In vito-peptid-ekspressionsbibliotek
DE69839444D1 (de) Smad 6 und dessen anwendungen
ES2085993T3 (es) Proteina asociada a la pancreatitis aguda, medios para el diagnostico de la pancreatitis aguda.
CY1106070T1 (el) Πολυμορφισμοι στο γονιδιο c μεταφορας οργανικου ανιοντος ανθρωπου (oatp-c) - (organic anion transporter c gene)
CY1110848T1 (el) Αντισωμα αντι ανθρωπου νοgo α kai h φαρμακευτικη του χρηση
CY1109207T1 (el) Διαδικασια εχινοκανδινης
CY1114526T1 (el) Κατασταλτικες πρωτεϊνες μιας πρωτεασης (protease) και χρησεις αυτων
DE60335726D1 (de) Chromoprotein und fluoroproteine
DE60122562D1 (de) Nukleinsäuren, die für stichodactylidae chromoproteine kodieren
DK1485481T3 (da) Fflourescerende protein fra Aequorea Coerulescens og anvendelser deraf
DK1576157T3 (da) Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme
BRPI0407031A (pt) Composições e métodos para tratamento de câncer empregando igsf9 e liv-1
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Legal Events

Date Code Title Description
FC Refusal